Provided by Tiger Trade Technology Pte. Ltd.

Verve Therapeutics

11.13
0.0000
Volume:- -
Turnover:114.94M
Market Cap:994.14M
PE:-5.30
High:11.13
Open:11.13
Low:11.13
Close:11.13
52wk High:11.41
52wk Low:2.86
Shares:89.32M
Float Shares:65.50M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1013
EPS(LYR):-2.3454
ROE:-34.26%
ROA:-19.35%
PB:2.10
PE(LYR):-4.75

Loading ...

Jan 24, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 24, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 17, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933